Konishi T, Nakano T. Comparison of the effects of various
vasodilators on the rat portal vein and mesenteric artery. Eur J Pharmacol 1993;242:129-136
34 Hartleb M, Michielsen PP, Dziurkowska-Marek A. The role of nitric oxide in portal hypertensive systemic and portal
vascular pathology. Acta Gastroenterol Belg 1997;60:222-232
35 Luscher TF, Yang Z, Tschudi M, von Segesser L, Stulz P, Boulanger C, Siebenmann R, Turina M, Buhler FR. Interaction
between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. Circulation Res
1990;66:1088-1094
36 Cahill PA, Redmond EM, Sitzmann JV. Endothelial dysfunction in cirrhosis and portal hypertension. Pharmacol Ther
2001;89:273-293
37 George J, Roulot D, Koteliansky VE, Bissell DM. In vivo inhibition of rat stellate cell activation by soluble transforming
growth factor beta type II receptor: a potential new therapy for hepatic fibrosis. Proc Natl Acad Sci USA
1999;96:12719-12724
38 Schlumberger W, Thiem M, Rauterberg J, Robenek H. Collagen synthesis in cultured aortic smooth muscle cells.
Modulation by collagen lattice culture transforming growth factor-beta 1 and epidermal growth factor. Arterioscler
Thromb 1991;11:1660-1666
39 O'Callaghan CJ, Williams B. Mechanical strain-induced extracellular matrix production by human vascular smooth
muscle cells: role of TGF-beta(1). Hypertension 2000;36:319-324
40 << 上一页 [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] 下一页
|
